The Next GLP-1 Wave: How Oral Launches Could Accelerate Utilization and Risk GLP-1 agents have reshaped the management of obesity, and the market continues to accelerate as new agents and indications emerge
Although ghrelin has been shown to increase cortisol secretion when given in infusion (108-110), ghrelin is suppressed after eating, making it an unlikely mediator of the post-prandial cortisol response
GLP-3 Retatrutide represents the third generation of GLP-1based weight-loss drugs
Glucagon-like peptide-1 receptor agonist liraglutide ameliorates the development of periodontitis
Thus, macrophages extracted from human liver should be referred as liver macrophages rather than Kupffer cells only
Reduction of DHT: GHK-Cu, when combined with other peptides, can inhibit 5-alpha-reductase, the enzyme that converts testosterone into DHTa key contributor to male pattern baldness